Kizoo_Logo for GNW.jpg
Kizoo Portfolio Company Underdog Closes $10M Financing Round
September 23, 2021 07:00 ET | KIZOO Technology Capital GmbH
MOUNTAIN VIEW, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Underdog Pharmaceuticals, a key investment of Michael Greve's rejuvenation biotech VC Kizoo, has closed a $10 million round of capital....
Underdog Pharmaceuticals Awarded ‘Innovation Passport’ by UK Regulators
September 08, 2021 11:00 ET | Underdog Pharmaceuticals Inc.
MOUNTAIN VIEW, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Underdog Pharmaceuticals, Inc. (Underdog), a pre-clinical stage pharmaceutical company focusing on the treatment and reversal of age-related...
AMR Logo.png
Inflation Devices Market Size to Reach Valuation of $770 million by 2026 | AMR
February 15, 2021 10:00 ET | Allied Market Research
Portland, OR, Feb. 15, 2021 (GLOBE NEWSWIRE) -- According to the report, the global inflation devices market was valued at $517 million in 2018, and is expected to reach $770 million by 2026,...
Clinical Highlights: 15th Annual CMHC Live Online
October 29, 2020 13:09 ET | Cardiometabolic Health Congress
Boca Raton, FL, Oct. 29, 2020 (GLOBE NEWSWIRE) -- The 15th Annual CMHC Live Online concluded on Saturday, October 24th. For the first time in its history, the event was delivered entirely online to...
SRF Logo.jpg
Novel therapeutic approach to cardiovascular disease from SENS Research Foundation flagship research program graduates from laboratory to the biotech world
November 14, 2019 07:00 ET | SENS Research Foundation
Kizoo Technology Capital leads seed round financing at Underdog Pharmaceuticals SRF announces leadership appointments MOUNTAIN VIEW, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Underdog...
Associates in Cardiovascular Disease and Admera Health Unveiled a Health Economics Model at the 2017 National Lipid Association Conference Detailing the Cost Benefits of Genetic Testing for Familial Hypercholesterolemia
May 23, 2017 09:25 ET | Admera Health, LLC
SOUTH PLAINFIELD, N.J., May 23, 2017 (GLOBE NEWSWIRE) -- Admera Health, a molecular diagnostics company developing comprehensive genetic tests for risk assessment and early diagnosis of...
PCSK9 Barriers Survey Results Revealed at National Lipid Association Conference
February 07, 2017 09:30 ET | National Lipid Association
PHOENIX, AZ--(Marketwired - February 07, 2017) - As part of its Spring Clinical Lipid Update (CLU) in Phoenix, the National Lipid Association (NLA) will reveal the results of its "Challenges in...
Leading Cardiologist Dr. Neil Stone Secured as Speaker for the National Lipid Association Conference
July 18, 2016 12:47 ET | National Lipid Association
JACKSONVILLE, FL--(Marketwired - July 18, 2016) - Award-winning cardiologist, Neil J. Stone, MD, FACC, FNLA, will be the keynote speaker at the National Lipid Association (NLA) Clinical Lipid Update...
Admera Health Launches Molecular Test for Inherited Early Atherosclerosis Diagnosis and Risk
March 17, 2016 07:00 ET | Admera Health, LLC
SOUTH PLAINFIELD, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- Admera Health (, a commercial stage New Jersey based Precision Medicine and Digital Health company announced today the...
National Lipid Association Releases Its Annual Summary of Clinical Lipidology 2016
February 22, 2016 11:37 ET | National Lipid Association
JACKSONVILLE, FL--(Marketwired - February 22, 2016) - The National Lipid Association's (NLA) Annual Summary of Clinical Lipidology 2016 was just published the Journal of Clinical Lipidology....